A two-site model for antiestrogen action

Mechanisms of Ageing and Development

Volumn 125, Issue 10-11 SPEC. ISS., 2004, Pages 679-682

  Jensen, Elwood V ^a   Khan, Sohaib A ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

Agonist antagonist activity; Antiestrogens; Estrogen receptor; Secondary binding

Indexed keywords

4 HYDROXYTAMOXIFEN; ANTIESTROGEN; ESTRADIOL; ESTROGEN RECEPTOR; HYDROXYTAMOXIFEN; RECEPTOR BLOCKING AGENT; TAMOXIFEN;

BINDING AFFINITY; BINDING SITE; DRUG ACTIVITY; DRUG RECEPTOR BINDING; GENITAL SYSTEM; GUINEA PIG; HORMONE RECEPTOR INTERACTION; MACROMOLECULE; MOLECULAR MODEL; NONHUMAN; PRIORITY JOURNAL; RECEPTOR OCCUPANCY; REVIEW; TISSUE LEVEL; UTERUS;

CAVIA PORCELLUS; SUS SCROFA;

EID: 8344221130     PISSN: 00476374     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mad.2004.08.006     Document Type: Article

References (19)

1. Y. Berthois, M. Pons, C. Dussert, A. Crastes de Paulet, and P.-M. Martin Agonist-antagonist activity of anti-estrogens in the human breast cancer cell line MCF-7: a hypothesis for the interaction with a site distinct from the estrogen-binding site Mol. Cell. Endocrinol. 99 1994 259 268
2. L.J. Black, C.D. Jones, and J.F. Falcone Antagonism of estrogen action with a new benzothiophene-derived antiestrogen Life Sci. 32 1983 1031 1036
3. A. Hedden, V. Müller, and E.V. Jensen A new interpretation of antiestrogen action Ann. N. Y. Acad. Sci. 761 1995 109 120
4. E.V. Jensen Steroid hormones, receptors, and antagonists Ann. N. Y. Acad. Sci. 784 1996 1 17
5. E.V. Jensen The curious pharmacology of the antiestrogens J. Li S.A. Li J.R. Daling Hormonal Carcinogenesis III 2001 Springer-Verlag New York 139 143
6. V.C. Jordan, and C.S. Murphy Endocrine pharmacology of antiestrogens as antitumor agents Endocr. Rev. 11 1990 578 610
7. B.S. Katzenellenbogen, K.L. Kendra, M.J. Norman, and Y. Berthois Proliferation, hormonal responsiveness and estrogen receptor content of MCF-7 human breast cancer cells grown in the short-term and long-term absence of estrogens Cancer Res. 47 1987 4355 4360
8. D.T. Kiang, R. Kollander, S. Schulstrom, and B.J. Kennedy Modulation of estrogen receptor (ER) from tamoxifen in human breast cancer Proc. Am. Assoc. Cancer Res. 28 1987 234 (Abstract)
9. H. Magdelenat, S. Merle, and A. Zajdela Enzyme immunoassay of estrogen receptors in fine needle aspirates of breast tumors Cancer Res. 46 1986 4265s 4267s
10. P.-M. Martin, Y. Berthois, and E.V. Jensen Binding of antiestrogens exposes an occult antigenic determinant in the human estrogen receptor Proc. Natl. Acad. Sci. U.S.A. 85 1988 2533 2537
11. 3 cellular signaling Proc. Natl. Acad. Sci. USA 101 2004 12876 12881
12. M. Nakao, B. Sato, M. Koga, K. Noma, S. Kishimoto, and K. Matsumoto Identification of immunoassayable receptor lacking hormone-binding ability in tamoxifen-treated rat uterus Biochem. Biophys. Res. Commun. 132 1985 336 342
13. R. Poulin, Y. Merand, D. Poirier, C. Levesque, J.-M. Dufour, and F. Labrie Anti-estrogenic properties of keoxifene, trans-4-hydroxytamoxifen and ICI 164384 a new steroidal antiestrogen in ZR-75-1 human breast cancer cells Breast Cancer Res. Treat. 14 1989 65 76
14. V.V. Tyulmenkov, and C.M. Klinge Interaction of tetrahydrochrysene ketone with estrogen receptors alpha and beta indicates conformational differences in the receptor subtypes Arch. Biochem. Biophys. 381 2000 135 142
15. P. Van de Velde, F. Nique, F. Bouchoux, J. Brémaud, M.-C. Hameau, D. Lucas, C. Moratille, S. Viet, D. Philibert, and G. Teutsch RU 58668 a new pure anti-estrogen inducing a regression of human mammary carcinoma implanted in nude mice J. Steroid Biochem. Mol. Biol. 48 1994 187 196
16. W.P. van Hoorn Identification of a second binding site in the estrogen receptor J. Med. Chem. 45 2002 584 589
17. A.E. Wakeling, and J. Bowler Novel antioestrogens without partial agonist activity J. Steroid Biochem. 31 1988 645 653
18. A.E. Wakeling, M. Dukes, and J. Bowler A potent specific pure antioestrogen with clinical potential Cancer Res. 51 1991 3867 3873
19. Wang, W., Chirgadze, N.Y., Briggs, S.L., Khan, S., Jensen, E.V., Burris, T.P. A second binding site for hydroxy-tamoxifen within the coactivator-binding groove of estrogen receptor beta. Proc. Natl. Acad. Sci. USA., submitted for publication.